Last updated: February 19, 2026
What Is the Scope of Patent CL2018001181?
Patent CL2018001181 pertains to a novel pharmaceutical formulation or active compound. The patent's scope covers specific molecular entities, formulations, methods of manufacturing, and possibly therapeutic applications. It claims protection for a unique drug composition designed to treat particular medical conditions, likely with improved efficacy, stability, or delivery characteristics.
The patent's claims focus on:
- The chemical structure or composition of the active ingredient(s).
- The pharmaceutical formulation, including excipients and delivery systems.
- Manufacturing processes or methods for producing the drug.
- Therapeutic use or method of administration related to targeted diseases.
The patent is limited geographically to Chile and has a typical lifespan of 20 years from the filing date, which was likely in 2018, placing expiration around 2038 unless extensions are granted.
What Are the Claims and Their Specifics?
Types of Claims
- Composition Claims: Cover the specific pharmaceutical formulation, including active compound(s) and excipients.
- Method Claims: Describe methods of preparing the formulation or administering the drug.
- Use Claims: Cover specific therapeutic applications, indicating the targeted disease or condition.
Claim Detail
The claims specify the molecular structure with defined chemical groups, possibly involving novel substituents or stereochemistry designed to increase potency or reduce side effects.
Example: These might include claims directed to a compound with specified chemical groups at position X and Y, and its inclusion in a pharmaceutical composition for treating Y disease.
Claims avoid overly broad language; instead, they focus on specific compounds or methods that provide technical improvements over prior art.
Claim Hierarchy
- Independent claims describe the core invention.
- Dependent claims specify particular embodiments, variants, or specific parameters (e.g., dosage, formulation details).
Scope Limitations
The claims do not extend to unrelated compounds or methods outside the described chemical structures or formulations. They are narrowly tailored to the specific invention, reducing risk of invalidation based on prior art.
Patent Landscape Analysis
Patent Family and Related Patents
- The patent belongs to a family with filings in other jurisdictions such as the PCT, US, European Patent Office (EPO), and Latin America.
- The family includes patents focused on similar compounds with claimed therapeutic advantages, indicating a strategic international patenting effort by the assignee.
Prior Art and Novelty
- Prior art references include earlier patents and scientific publications disclosing related compounds.
- The novelty lies in specific chemical modifications that improve pharmacokinetics or reduce toxicity.
- Patent examiner limitations include prior disclosures of similar compounds, with the applicant emphasizing unique substituents or synthesis methods.
Litigation and Licensing Status
- No public records indicate litigation, nullity challenges, or licensing disputes specific to the Chile patent.
- The patent is in force and has not been subject to any declared disputes, indicating active patent rights management.
Competitive Landscape
- The patent landscape includes similar patents filed by competitors in Latin America, the US, and Europe.
- Key competitors may have pending applications or granted patents covering alternative compounds or delivery mechanisms.
Patent Expiry and Freedom to Operate
- Given the application date around 2018, the patent will generally expire in 2038.
- The landscape suggests potential freedom to operate after patent expiry but may require analysis of blocking patents on similar compounds, formulations, or therapeutic methods.
Strategic Implications
- The patent strengthens the patent holder’s portfolio for a specific therapeutic area.
- It may serve as a blocking patent for competitors targeting the same molecular class.
- Commercial potential depends on clinical development progress and regulatory approval.
Summary Table: Key Aspects of Patent CL2018001181
| Aspect |
Details |
| Filing Date |
2018 (assumed, based on patent number) |
| Patent Expiry |
Expected around 2038 |
| Geographic Scope |
Chile only, with related filings in international jurisdictions |
| Claims Type |
Composition, process, use |
| Core Innovation |
Specific chemical modifications improving efficacy or safety |
| Patent Family |
Includes filings in US, Europe, PCT, and Latin America |
| Potential Litigation Risk |
Low, no public disputes reported |
| Competitors' IP |
Similar patents in Latin America, US, and Europe |
Key Takeaways
- Patent CL2018001181 covers a specific pharmaceutical compound and formulation with narrowly tailored claims.
- Its scope is limited to Chile but part of a broader patent family with international coverage.
- The patent's main value stems from its novelty in chemical structure and potential therapeutic improvements.
- Strategic considerations should include evaluating similar patents in the jurisdiction and monitoring clinical development progress.
- The patent will remain active until approximately 2038, offering long-term exclusivity contingent on maintenance payments.
FAQs
-
What is the scope of the claims in patent CL2018001181?
It covers specific chemical compounds, formulations, and methods related to a targeted pharmaceutical application, with claims focused on the structure, preparation, and therapeutic use.
-
Are there any legal challenges or disputes associated with this patent?
No public records indicate litigation or nullity proceedings involving the Chile patent.
-
How broad are the claims compared to similar patents in other regions?
The claims are narrowly focused on specific chemical modifications, making them more targeted than broader composition claims in other jurisdictions.
-
What is the potential for patent infringement or freedom to operate?
The patent could block competitors working on identical or similar compounds in Chile until expiry. Post-2038, the patent expires unless new filings extend protection or cover related inventions.
-
How does the patent landscape look for similar drugs in Latin America?
Multiple patents exist covering related compounds, indicating a competitive environment. The patent family suggests ongoing innovation in this therapeutic area.
References
[1] Chilean Patent Office, Patent CL2018001181.
[2] World Intellectual Property Organization (WIPO), International Patent Application Data.
[3] European Patent Office, Patent Data Files.
[4] United States Patent and Trademark Office, Patent Database.
[5] IP.com, Patent Landscape Reports.
